BioNTech

Pfizer and BioNTech are seeking authorization from the Food and Drug Administration to authorize a second COVID-19 booster shot for people 65 and older. They plan to seek emergency authorization for this additional booster for older adults to strengthen protections against the omicron variant. Even though restrictions have been lifted, vaccines do still provide protection […]

In a new clinical trial announced yesterday, Pfizer and BioNTech have begun a clinical trial to evaluate a new, omicron-specific vaccine for COVID-19. Even though people who are vaccinated and boosted appear to be better protected against severe COVID symptoms and hospitalization from omicron, the new highly contagious variant has still led to breakthrough cases […]

Officials are speculating that the deal brokered with the pharmaceutical companies Johnson & Johnson and Merck will advance the overall vaccine distribution timeline by a couple of months. President Joe Biden said on Tuesday that he thinks that every willing adult in the US could be vaccinated as soon as April. There should be around […]

The pharmaceutical giants Pfizer and BioNTech have announced that they have signed an agreement with the U.S. Department of Health and Human Services and the Department of Defense to deliver almost 300 million does of a COVID-19 Vaccine by 2021. The government’s plan is called Operation Warp Speed and it’s designed as part of a […]

Pfizer and BioNTech have been hard at work researching and testing a possible vaccine against the coronavirus. On Wednesday, the pharmaceutical companies announced that initial trials looked promising and seemed optimistic about the future of the vaccine. In the most recent trial, 45 people were tested. 36 of them received the vaccine and 9 got […]

Members of Rochester Regional Health and UR Medicine are starting to recruit people to enlist in a clinical trial partnership with BioNTech and Pfizer to develop a COVID-19 vaccine. Rochester General Hospital is now testing candidates and researchers say their goals are to have a vaccine ready for emergency use by 2021. The study consists […]